Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pipecuronium is a steroidal nondepolarizing neuromuscular blocking agent.1 It binds to nicotinic acetylcholine receptors (nAChRs; apparent Kd = 3.06 µM).2 Pipecuronium reverses pilocarpine-induced decreases in electric field stimulation-induced contractions in human bronchial rings, indicating that it acts as a muscarinic AChR (mAChR) antagonist.3 It induces neuromuscular block in pigs (ED95 = 150 µg/kg).4 Formulations containing pipecuronium have previously been used as neuromuscular blocking agents.
WARNING This product is not for human or veterinary use.
1. New developments in nondepolarizing muscle relaxants. Yale J. Biol. Med. 66(5), 463-471 (1994).
2. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202(3), 297-302 (1991).
3. Do pipecuronium and rocuronium affect human bronchial smooth muscle? Anesthesiology 91(6), 1616-1621 (1999).
4. Dose requirements and plasma concentrations of pipecuronium during bilateral renal exclusion and orthotopic liver transplantation in pigs. Br. J. Anaesth. 65(6), 779-785 (1990).